Flubromazepam Pellets (8mg)

Flubromazepam Pellets (8mg) are a precision-formulated research chemical product specifically designed for laboratory applications and analytical studies. Flubromazepam, a member of the benzodiazepine family, is known for its unique chemical properties and structural stability, providing reliability and consistency in various research domains. These pellets are meticulously manufactured for professional use to ensure accurate dosing and optimal quality.

Composition and Pharmacology

Each pellet contains 8 milligrams of Flubromazepam as the active ingredient. Chemically classified as 7-bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one, it exhibits a molecular formula of C15H10BrFN2O and a molecular weight of 333.157 g/mol. This compound has been synthesized to maintain precise structural integrity, facilitating its study in pharmacokinetics, binding affinities, and other biochemical analyses.

Flubromazepam interacts primarily with the gamma-aminobutyric acid (GABA-A) receptors, a key neurotransmitter site in the central nervous system. Research indicates it has high binding affinity to these receptor sites, making it an essential point of interest for studies on anxiolytic, anticonvulsant, sedative, and muscle-relaxing properties. However, further research is encouraged to better understand its long-term metabolic pathways and receptor involvement.

Manufacturing Standards and Quality Assurance

Flubromazepam Pellets are developed in a state-of-the-art facility adhering to rigorous Good Manufacturing Practices (GMP). During production, the compound undergoes multiple stages of quality control, including advanced spectroscopy and chromatography methods, to ensure purity, potency, and consistency. Each pellet meets laboratory-grade standards, making it a reliable choice for professional and academic study.

These 8mg pellets are formed using precision-pressing technology to maintain uniformity in size, weight, and active ingredient dispersion. This ensures accurate measurements for controlled experiments.

Recommended Applications

Flubromazepam Pellets are intended for in-vitro studies and other laboratory research purposes. Their structural and chemical characteristics make them well-suited for:

• Binding affinity studies to analyze interactions with GABA-A receptors.
• Development of analytical techniques for benzodiazepines.
• Testing and calibration of detection instruments.
• Studies on metabolism and degradation under specific conditions.

Storage and Stability

For optimal preservation of Flubromazepam’s chemical stability, these pellets should be stored in a cool, dry place away from direct sunlight, heat, and moisture. A controlled temperature environment, ideally between 20°C to 25°C (68°F to 77°F), is recommended. Proper storage ensures the integrity of the pellets over their extended shelf life. Users must handle the pellets with care, following standard laboratory safety protocols, including the use of gloves and protective eyewear.

Safety and Legal Notice

Flubromazepam Pellets are strictly for research use only and are not intended for human or animal consumption. Researchers must ensure compliance with all local, state, and international regulations regarding the handling and use of benzodiazepine compounds in laboratory settings. Proper safety measures should be followed to minimize exposure risks, and disposal should align with chemical waste management guidelines.

It is imperative that the purchaser is a qualified professional or institution capable of handling and studying controlled substances. Unauthorized or improper use may have legal consequences and pose serious risks.

Disclaimer

No claims are made regarding the suitability of this compound for medical or therapeutic use. All data and descriptions are provided solely for informational purposes related to research and development. Ensure that research involving Flubromazepam aligns with ethical guidelines and institutional standards.

By selecting Flubromazepam Pellets (8mg), researchers gain access to a high-quality, tested product essential for advancing scientific knowledge in the field of benzodiazepine analogs